Skip to main content

Dr. David G. Telander, M.D., PH.D

Retina Specialist (Retina Specialist (Ophthalmology) Physician)

  • Medicare participating

At a glance

Years since graduation
27
In the NPI registry since
2005
Medicare patients seen, 2024
1,672

Licensed in California since 2003, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1999Medical school: University of Minnesota Medical School
  • 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Retina Specialist (Ophthalmology) Physician primary
    CA license A82894 (first issued 2003; current)
  • Ophthalmology Physician
    CA license A82894 (first issued 2003; current)

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Retina Specialist per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
1,672
Services billed
69,193
Patients’ average age
76
Most frequent Medicare services, 2023
ServiceTimesPatients
Injection, faricimab-svoa, 0.1 mg25,740122
Imaging of retina3,7061,618
Injection, aflibercept, 1 mg2,522351
Established patient complete exam of visual system2,3391,337
Injection of drug into eye1,855556
Injection, ranibizumab, 0.1 mg1,32188
Exam of retinal blood vessels using a special camera after injection of a dye345329
New patient complete exam of visual system213213
Injection, dexamethasone, intravitreal implant, 0.1 mg17514
Extended exam of the back part of the eye with retinal drawing123117

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 12 companies reported 34 payments worth $1,901 in total to this clinician.

By type
Food and Beverage$1,358
Consulting Fee$544

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Jan 30, 2025AbbVie Inc.
Jan 30, 2025
Consulting Fee
OZURDEX · EYE CARE
$544

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in California →

Industry-funded research

Named as a principal investigator on 5 industry-funded studies in 2025, from 3 companies. The companies reported $144,353 in research payments for these studies, mostly to the institutions running them.

  • Phase IIa Geographic Atrophy Study
    Genentech, Inc.
  • Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy
    AbbVie Inc.
  • Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy (RGX-314 SRLTFU)
    AbbVie Inc.
  • NRICH
    Notal Vision, Inc.
  • Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy
    AbbVie Inc. · Enrolling by invitation · NCT03999801

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Retina Specialist clinicians in Sacramento

Sources

NPI registry (CMS NPPES, November 2026; record last updated April 3, 2017), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1528043023. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.